Printer Friendly

Articles from M2 Pharma (July 20, 2017)

1-32 out of 32 article(s)
Title Author Type Words
Ablynx and Sanofi enter strategic collaboration to develop Nanobody product candidates. 232
AcelRx Pharmaceuticals Names Asadorian as Chief Financial Officer. 221
Akcea Therapeutics closes IPO at USD8.00 per share. 163
AMO Pharma agrees development and licence deal with Numedicus. 187
Aspyrian Therapeutics Inc concludes USD15.1m Series B-1 financing agreement. 304
Bioniz Therapeutics Provides Results from Multi-Cytokine Inhibitor BNZ-1 Clinical Study. Clinical report 251
Celyad initiates SHRINK trial for lead product candidate CYAD-01. 205
CSL Behring submits supplemental BLA for Hizentra with the US FDA for treating Chronic Inflammatory Demyelinating Polyneuropathy. 285
CSL Behring's Supplemental Biologics License Application for Hizentra for CIPD Accepted for Review by FDA. 348
Dicerna Expands Lead GalXCDevelopment Program to Encompass All Forms of Primary Hyperoxaluria and Reveals New Therapeutic Target for DCR-PHXC. 508
Evolus submits DWP-450 Neuromodulator's BLA with US FDA for treatment of glabellar lines. 168
GlaxoSmithKline announces UK manufacturing changes. 373
Global Alzheimer's Drugs Market to Grow at a CAGR of 1.9% by 2021, Research and Markets Forecasts. 347
Global Leukemia Therapeutics Market to Reach USD 2.6bn by 2025, Research and Markets Forecasts. 276
Gravie announces USD14.1m from Series C funding round. 111
Great Place to Work Institute honours Astellas Farma Brasil. 136
Imago BioSciences Begins Phase 2a of Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome. 219
Kala Pharmaceuticals Announces Prices USD 90m Initial Public Offering. 265
LEO Pharma granted marketing authorisation for Kyntheum in Europe. 222
Licence agreement between Basilea and Pfizer for antifungal Cresemba is complete. 205
ModGene Pharma US Patent Allowance Supports Alzheimer's Disease Prevention. 431
Mycoplasma Testing Market to Reach USD 934m by 2022, Research and Markets Forecasts. 332
Myovant Sciences names new general counsel and corporate secretary. 138
Perrigo wins final US FDA approval for generic DermOtic Oil, 0.01% ear drops. 186
Prana Biotechnology signs research collaboration with Takeda Pharmaceuticals. 142
Quest Diagnostics Releases Pan-Ethnic Genetic Screening Service. 293
Regulus anticipates USD37.3m from public offering of common shares. 201
Sarepta Therapeutics and BioMarin Pharmaceutical settle global patent litigation. 176
Sobi's board authorises repurchase of C class shares. 340
Sobi's profit own by 21% in Q2 2017. Financial report 218
Universal Health Services' board approves USD0.10 per share dividend. 138
US FDA grants approval to Gilead Sciences' Vosevi. 232

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters